Molecular docking and CoMFA studies of thiazoloquin(az)olin(on)es as CD38 inhibitors: determination of inhibitory mechanism, pharmacophore interactions, and design of new inhibitors.
about
Molecular docking and CoMFA studies of thiazoloquin(az)olin(on)es as CD38 inhibitors: determination of inhibitory mechanism, pharmacophore interactions, and design of new inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Molecular docking and CoMFA st ...... and design of new inhibitors.
@en
Molecular docking and CoMFA st ...... and design of new inhibitors.
@nl
type
label
Molecular docking and CoMFA st ...... and design of new inhibitors.
@en
Molecular docking and CoMFA st ...... and design of new inhibitors.
@nl
prefLabel
Molecular docking and CoMFA st ...... and design of new inhibitors.
@en
Molecular docking and CoMFA st ...... and design of new inhibitors.
@nl
P2860
P1476
Molecular docking and CoMFA st ...... , and design of new inhibitors
@en
P2093
Raouf Ghavami
P2860
P304
P356
10.1080/07391102.2016.1197152
P577
2016-09-26T00:00:00Z